Meeting the 12 Lymph Node (LN) benchmark in colon cancer

Journal of Surgical Oncology

Volumn 102, Issue 1, 2010, Pages 3-9

  Rajput, A ^a   Romanus, D ^b   Weiser, M R ^c   Ter Veer, A ^d   Niland, J ^d   Wilson, J ^e   Skibber, J M ^f   Wong, Y N ^g   Benson, A ^h   Earle, C C ^b   Schrag, D ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g FOX CHASE CANCER CENTER   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Colon cancer; Lymph nodes; Outcomes

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY CONTROL; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BENCHMARKING; COHORT STUDIES; COLONIC NEOPLASMS; DATABASES, FACTUAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SEER PROGRAM; YOUNG ADULT;

EID: 77954105801     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21532     Document Type: Article

References (36)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics. CA Cancer J Clin 2008;58:71-96.
2. Colon and Rectum. In: Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging handbook. 6th edition. New York: Springer; 2002. pp. 127-138.
3. Andre T, Boni C, Mounedji-Boudiaf L, et al.: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343-2351.
4. Chau I, Cunningham D: Adjuvant therapy in colon cancer: What, when and how? Ann Oncol 2006;27:1347-1359.
5. Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al.: Lymph node evaluation and survival after curative resection of colon cancer: Systematic review. J Natl Cancer Inst 2007;99:433-441. (Pubitemid 47073566)
6. Benson AB, Schrag D, Somerfield MR, et al.: American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Orthod 2004;22:3408-3419.
7. Le Voyer TE, Sigurdson ER, Hanlon AL, et al.: Colon cancer survival is associated with increasing number of lymph nodes analyzed: A secondary survey of intergroup trial INT-0089. J Clin Oncol 2003;21:2912-2919.
8. Swanson RS, Compton CC, Stewart AK, et al.: The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003;10:65-71.
9. Joseph NE, Sigurdson ER, Hanlon AL, et al.: Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol 2003; 10:213-218.
10. Wong JH, Severino R, Honnebier MB, et al.: Number of nodes examine and staging accuracy in colorectal carcinoma. J Clin Oncol 1999;17:2896-2900. (Pubitemid 29415250)
11. Goldstein NS, Sanford W, Coffey M, et al.: Lymph node recovery from colorectal resection specimens removed for adenocarcinoma: Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 1996; 106:209-16. (Pubitemid 26277211)
12. Leibl S, Tsybrovskyy O, Denk H: How many lymph nodes are necessary to stage early and advanced adenocarcinoma of the sigmoid colon and upper rectum. Virchows Arch 2003;443:133-138. (Pubitemid 37056136)
13. Bui L, Rempel E, Reeson D, et al.: Lymph node counts rates of positive lymph nodes and patient survival for colon cancer surgery in Ontario, Canada: A population-based study. J Surg Oncol 2006; 93:439-445. (Pubitemid 44651266)
14. Wang J, Kulaylat M, Rockett H, et al.: Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer. Ann Surg (in press).
15. Johnson PM, Porter GA, Ricciardi R, et al.: Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 2006;24:3570-3575. (Pubitemid 46630528)
16. Chen SL, Bilchik AJ: More extensive nodal dissection improves survival for Stage I to III colon cancer: A population-based study. Ann Surg 2006;244:602-610.
17. Wang J, Hassett J, Dayton MT, et al.: Lymph node ratio: Role in the staging of node-positive colon cancer. Ann Surg Oncol 2008; 15:1600-1608.
18. Berger AC, Sigurdson ER, Le Voyer T, et al.: Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 2005;23:8706-8712. (Pubitemid 46211514)
19. Frederique P, Stephane B, Catherine J, et al.: The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. Ann Surg 2008;248:1067-1073.
20. Rosenberg R, Friderichs J, Schuster T, et al.: Prognosis of patients with colorectal cancer is associated with lymph node ratio. Ann Surg 2008;248:968-978.
21. Lee H-Y, Choi H-J, Park K-J, et al.: Prognostic significance of metastatic lymph node ration in node-positive colon carcinoma. Ann Surg Oncol 2007;14:1712-1717.
22. Jass JR, O'Brien MJ, Riddell RH, et al.: Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Hum Pathol 2007;38:537-545.
23. Compton CC: Members of the Cancer Committee, College of American Pathologists. Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix. Arch Pathol Lab Med 2000;124:1016-1025.
24. NCCN: http://www.nccn.org/professionals/quality-measures/PDF/ colon-quality-measures.pdf, last accessed 3/25/2008.
25. FACS: http://www.facs.org/cancer/qualitymeasures.html, last accessed 9/22/2008.
26. National Quality Forum: http://www.qualityforum.org/pdf/cancer/ txAppA-Specifications-web.pdf, last accessed 9/22/2008.
27. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Limited-Use Data (1973-2005), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission.
28. Charlson ME, Pompei P, Ales KL, et al.: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 1987;40:373-383.
29. Wong SL, Ji H, Hollenbeck BK, et al.: Hospital lymph node examination rates and survival after resection for colon cancer. JAMA 2007;298:2149-2154.
30. Baxter NN, Virnig DJ, Rothenberger DA, et al.: Lymph node evaluation in colorectal cancer patients: A population-based study. J Natl Cancer Inst 2005;97:65-71.
31. Nelson H, Petrelli N, Carlin A, et al.: Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001;93:583-596.
32. Scott KWM, Grace RH: Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 1989;76:1165-1167. (Pubitemid 19284443)
33. Brown HG, Luckasevic TM, Medich DS, et al.: Efficacy of manual dissection of lymph nodes in colon cancer resections. Mod Pathol 2004;17:402-406. (Pubitemid 41646594)
34. Wright FC, Law CH, Last L, et al.: Lymph node retrieval and assessment in stage II colorectal cancer: A population-based study. Ann Surg Oncol 2003;10:903-909. (Pubitemid 40486855)
35. Gorog D, Nagy P, Peter A, et al.: Influence of obesity on lymph node recovery from rectal cancer specimens. Pathol Oncol Res 2003;9:180-183. (Pubitemid 37429498)
36. Bilimoria KY, Bentrem DJ, Stewart AK, et al.: Lymph node evaluation as a colon cancer quality measure: A national hospital report card. J Natl Cancer Inst 2008;100:1310-1317.